Evidence map›Paper›PMID 34732716›Full record

ArticleNature communications2021

Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.

Tatenda Mahlokozera, Bhuvic Patel, Hao Chen, Patrick Desouza, Xuan Qu, Diane D Mao, Daniel Hafez, Wei Yang, Rukayat Taiwo, Mounica Paturu and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 59 citations in OpenAlex.

  1. Ubiquitination plays a key role in an insecticide resistance fitness cost.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Tatenda MahlokozeraDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Bhuvic Patel *Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-8062-7310
Hao Chen *Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Patrick DesouzaDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Xuan QuDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0003-1436-3315
Diane D MaoDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Daniel HafezDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Wei YangDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Rukayat TaiwoDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Mounica PaturuDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Afshin SalehiDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Amit D GujarDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0003-0689-6680
Gavin P DunnDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Nima MosammaparastDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-5453-5914
Allegra A PettiDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-6884-6107
Hiroko YanoDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA. yanoh@wustl.edu.ORCID 0000-0001-6548-0920
Albert H KimDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA. alberthkim@wustl.edu.ORCID 0000-0002-1751-8493
Neurological Surgery · USWashington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
REGULATION OF NEURONAL DEVELOPMENT BY UBIQUITIN PATHWAYSR01NS051255 · NINDS · WASHINGTON UNIVERSITY · PI KIM, ALBERT HONG-JAE · 2005 to 2020
$5.6M
NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy ResistanceR01NS106612 · NINDS · WASHINGTON UNIVERSITY · PI KIM, ALBERT HONG-JAE · 2019 to 2023
$2.1M
Role of DNA methyltransferases in Huntington's diseaseR01NS111014 · NINDS · WASHINGTON UNIVERSITY · PI YANO, HIROKO · 2019 to 2023
$2.0M
Regulation of Glioblastoma Stem-Like Cells by CDC20-Anaphase-Promoting ComplexR01NS094670 · NINDS · WASHINGTON UNIVERSITY · PI KIM, ALBERT HONG-JAE · 2016 to 2020
$1.7M
IVIS Spectrum CT Preclinical In Vivo Imaging SystemS10OD027042 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2019 to 2019
$599k
ZEISS LSM880 AIRYSCAN MICROSCOPE FOR SHARED BIOMEDICAL RESEARCHS10OD021629 · OD · WASHINGTON UNIVERSITY · PI FITZPATRICK, JAMES ALEXANDER · 2017 to 2017
$596k
NCI NIH HHS P30 CA091842NIH HHS S10 OD021629NIH HHS S10 OD027042NINDS NIH HHS R01 NS051255NINDS NIH HHS R01 NS094670NINDS NIH HHS R01 NS106612NINDS NIH HHS R01 NS111014
6 · The paper itself

Abstract

The pluripotency transcription factor SOX2 is essential for the maintenance of glioblastoma stem cells (GSC), which are thought to underlie tumor growth, treatment resistance, and recurrence. To understand how SOX2 is regulated in GSCs, we utilized a proteomic approach and identified the E3 ubiquitin ligase TRIM26 as a direct SOX2-interacting protein. Unexpectedly, we found TRIM26 depletion decreased SOX2 protein levels and increased SOX2 polyubiquitination in patient-derived GSCs, suggesting TRIM26 promotes SOX2 protein stability. Accordingly, TRIM26 knockdown disrupted the SOX2 gene network and inhibited both self-renewal capacity as well as in vivo tumorigenicity in multiple GSC lines. Mechanistically, we found TRIM26, via its C-terminal PRYSPRY domain, but independent of its RING domain, stabilizes SOX2 protein by directly inhibiting the interaction of SOX2 with WWP2, which we identify as a bona fide SOX2 E3 ligase in GSCs. Our work identifies E3 ligase competition as a critical mechanism of SOX2 regulation, with functional consequences for GSC identity and maintenance.

Indexed as

AnimalsB30.2-SPRY DomainBinding, CompetitiveBrain NeoplasmsFemaleGene Knockdown TechniquesGlioblastomaHEK293 CellsHumansMiceMice, Inbred NODMice, SCIDProteomicsSOXB1 Transcription FactorsTripartite Motif ProteinsUbiquitinationSOX2 protein, humanSOXB1 Transcription FactorsTRIM26 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesWWP2 protein, human

Identifiers

PMID34732716
PMCPMC8566473
OpenAlexW3208567322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.